Article Details

NovelMed reports interim positive data from Phase I trial of PNH asset

Retrieved on: 2022-02-22 10:08:53

Tags for this article:

Click the tags to see associated articles and topics

NovelMed reports interim positive data from Phase I trial of PNH asset. View article details on hiswai:

Excerpt

NM8074 only attaches to disease-specific Bb and not to Factor B of the alternative pathway (AP), which gives a significant advantage over various ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up